Dianthus Therapeutics, Inc.

1. 01

   Ahead of SPY and its sector fund XLV over 1 year

   1 month: +0.5% (SPY −1.6%, XLV +13.5%). 3 months: −23.7% (SPY −0.4%, XLV +15.5%). 1 year: +158.5% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: DNTH, SPY and XLV · as of 4 Nov 2026

2. 02

   Below its 50-day average, above its 200-day

   The 4 Nov 2026 close of $85.81 was 5.8% below its 50-day average ($91.11) and 0.2% above its 200-day average ($85.61). It has closed above the 200-day for 1 session, since 4 Nov 2026. The 50-day average crossed above the 200-day on 5 Sep 2025, 293 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

3. 03

   10.2 days to cover short interest

   9.0M shares were sold short at the 15 Oct 2026 settlement, 16.4% of the 54.8M shares outstanding; covering them would take 10.2 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

4. 04

   62% of the way up its 52-week range

   Closed at $85.81 on 4 Nov 2026: 27.2% below the 52-week high of $117.88 (19 Aug 2026) and 153.5% above the low of $33.85 (6 Nov 2025).

   Daily price bars, split-adjusted · as of 4 Nov 2026

5. 05

   Volume 1.8× its 30-session average on 4 Nov 2026

   4 Nov 2026 volume of 1.7M shares was 1.8× the average of the 30 sessions before it (919.3K), as the price rose 3.8%. SPY traded 1.5× its own average that session.

   Daily volume against a 30-session baseline · as of 4 Nov 2026

At the 4 Nov 2026 close